![Andrew Hirsch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Hirsch
Vorstandsvorsitzender bei
C4 THERAPEUTICS, INC.
Vermögen: 597 783 $ am 31.05.2026
Profil
Andrew J.
Hirsch is President, Chief Executive Officer & Director at C4 Therapeutics, Inc. since 2020.
Mr. Hirsch is an Independent Director at Editas Medicine, Inc. since 2017.
Formerly, Mr. Hirsch was CFO & Head-Corporate Development at Agios Pharmaceuticals, Inc. from 2018 to 2020.
Mr. Hirsch was President, CEO, CAO & Director at DNIB Unwind, Inc. in 2016.
Mr. Hirsch was Chief Financial Officer at Avila Therapeutics, Inc. from 2011 to 2012.
Mr. Hirsch was VP-Corporate Strategy, Mergers & Acquisitions at Biogen, Inc. from 2002 to 2011.
Mr. Hirsch completed undergraduate studies at the University of Pennsylvania in 1992.
Mr. Hirsch earned an MBA from Tuck School of Business at Dartmouth in 1997.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 22.04.2026 | 135’209 ( 0.12% ) | 590 863 $ | 31.05.2026 | |
| 17.06.2026 | 2’000 ( 0% ) | 6 920 $ | 31.05.2026 |
Aktive Positionen von Andrew Hirsch
| Unternehmen | Position | Beginn |
|---|---|---|
| EDITAS MEDICINE, INC. | Direktor/Vorstandsmitglied | 30.05.2017 |
| C4 THERAPEUTICS, INC. | Vorstandsvorsitzender | 02.10.2020 |
Ehemalige bekannte Positionen von Andrew Hirsch
| Unternehmen | Position | Ende |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 11.09.2020 |
| DNIB UNWIND INC | Vorstandsvorsitzender | 24.07.2016 |
Avila Therapeutics, Inc.
 Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops covalent drugs | Finanzdirektor/CFO | 31.03.2012 |
| BIOGEN INC. | Corporate Officer/Principal | 01.06.2011 |
Ausbildung von Andrew Hirsch
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
88
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology Develops biopharmaceutical preparations | Health Technology |
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avila Therapeutics, Inc.
Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops covalent drugs | Health Technology |
Tuck School of Business at Dartmouth
 Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
C4 Therapeutics, Inc.
 C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
Wählen Sie MarketScreener 
